BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//thebench.bio//Events//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:event-31@thebench.bio
DTSTAMP:20261011T090430Z
DTSTART;VALUE=DATE:20261120
DTEND;VALUE=DATE:20261121
SUMMARY:ASGCT Safety\, Translation and Real-World Implementation of AAV and
  LNP Gene Therapies
LOCATION:Morgan Center for Research and Innovation\, Children’s Hospital 
 of Philadelphia\, Philadelphia\, PA\, United States
DESCRIPTION:ASGCT and the Clinical In Vivo Gene Therapy group at Children's
  Hospital of Philadelphia run this one-day\, CME-accredited programme on b
 ringing AAV and LNP gene therapies safely into clinical practice. Five ses
 sions cover approved products and lessons learned\, early and delayed toxi
 cities\, and case studies on institutional implementation\, with speakers 
 including Beverly Davidson and Kevin Flanigan. It is aimed at clinicians\,
  translational researchers\, pharmacists and wider care teams.\n\nhttps://
 www.asgct.org/events-meetings/safety-translation-and-real-world-implementa
 tion-of-aav-and-lnp-gene-therapies
URL:https://thebench.bio/events/asgct-safety-translation-and-real-world-imp
 lementation-of-aav-and-lnp-gene-therapies-2026
END:VEVENT
END:VCALENDAR